Mahta Baghoolizadeh

Mahta Baghoolizadeh practices at UCI Department of Psychiatry in Newport Beach, California.

Mahta Baghoolizadeh's NPI, 1164927075, was assigned on March 24, 2018. Mahta Baghoolizadeh graduated from UC Irvine School of Medicine in 2018. Mahta Baghoolizadeh holds California license A166390.

Mahta Baghoolizadeh's primary practice is UCI Department of Psychiatry, at 20350 Sw Birch St, Newport Beach, CA 92660 in Orange County. The practice phone is (949) 824-1283.

Mahta Baghoolizadeh's primary practice is UCI Department of Psychiatry in Newport Beach, California. The medical group on file is UCI Department of Psychiatry & Human Behavior.

Dmand AI tracks the electronic health record (EHR) system at each site where Mahta Baghoolizadeh practices. Vendor and product names are available with a free account.

Psychiatry is Mahta Baghoolizadeh's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Mahta Baghoolizadeh is board certified in child & adolescent psychiatry by the American Board of Psychiatry and Neurology. Mahta Baghoolizadeh is licensed in California.

Dmand AI lists adjustment disease, anxiety, depression and insomnia among the conditions Mahta Baghoolizadeh treats.

CMS data shows 120 Medicare services from Mahta Baghoolizadeh across 2 procedure codes in 2024, all of them office visits, for 89 Medicare patients. Medicare paid $11,295 for them. Every service was in an office.

CMS counts 89 Medicare patients who saw Mahta Baghoolizadeh in 2024. The largest group is under 65, with 50 patients. 75% of them have anxiety, and 75% have mood disorders. 62% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mahta Baghoolizadeh's median patient age at 23, with 52% women.

In 2024, Mahta Baghoolizadeh wrote 13 Medicare Part D claims. 100% of them were for generic drugs. They cover 17 drugs, with $14,672 in total drug cost. In 2020, CMS named 138 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Mahta Baghoolizadeh for performance year 2024, reported through an alternative payment model (APM). Mahta Baghoolizadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mahta Baghoolizadeh as offering telehealth.

Dmand AI links 5 papers to Mahta Baghoolizadeh, published from 2015 to 2025. 2015 was the busiest year, with 2. Mahta Baghoolizadeh's most frequent co-authors are Gemma Deguzman Espejo, MD and Carolyn Elizabeth Cookson, MD.

Mahta Baghoolizadeh graduated from UC Irvine School of Medicine in 2018.

Mahta Baghoolizadeh is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.